BR112016025080A2 - método de tratamento de fibrose pulmonar idiopática. - Google Patents
método de tratamento de fibrose pulmonar idiopática.Info
- Publication number
- BR112016025080A2 BR112016025080A2 BR112016025080A BR112016025080A BR112016025080A2 BR 112016025080 A2 BR112016025080 A2 BR 112016025080A2 BR 112016025080 A BR112016025080 A BR 112016025080A BR 112016025080 A BR112016025080 A BR 112016025080A BR 112016025080 A2 BR112016025080 A2 BR 112016025080A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- pulmonary fibrosis
- idiopathic pulmonary
- idiopathic
- fibrosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461990603P | 2014-05-08 | 2014-05-08 | |
| US201462006692P | 2014-06-02 | 2014-06-02 | |
| US14/490,623 US20150321989A1 (en) | 2014-05-08 | 2014-09-18 | Method of treating idiopathic pulmonary fibrosis |
| PCT/US2015/029449 WO2015171749A2 (en) | 2014-05-08 | 2015-05-06 | Method of treating idiopathic pulmonary fibrosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112016025080A2 true BR112016025080A2 (pt) | 2017-10-17 |
Family
ID=54367219
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112016025080A BR112016025080A2 (pt) | 2014-05-08 | 2015-05-06 | método de tratamento de fibrose pulmonar idiopática. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US20150321989A1 (pt) |
| EP (2) | EP3763362B1 (pt) |
| JP (1) | JP6594899B2 (pt) |
| KR (1) | KR102445077B1 (pt) |
| CN (1) | CN106232108B (pt) |
| BR (1) | BR112016025080A2 (pt) |
| CA (1) | CA2946594C (pt) |
| ES (2) | ES2792850T3 (pt) |
| TW (1) | TW201622715A (pt) |
| WO (1) | WO2015171749A2 (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016085954A1 (en) * | 2014-11-26 | 2016-06-02 | Medicinova, Inc. | Geranygeranylacetone and analogs thereof and phenoxyalkylcarboxlic acids for treating fibrosis |
| KR102224539B1 (ko) * | 2019-04-17 | 2021-03-09 | 충북대학교 산학협력단 | 피르페니돈 및 아세틸시스테인의 공융혼합물 및 이의 제조방법 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2585246A1 (fr) | 1985-07-26 | 1987-01-30 | Cortial | Procede d'obtention de formes pharmaceutiques solides a liberation prolongee |
| US4788055A (en) | 1985-12-09 | 1988-11-29 | Ciba-Geigy Corporation | Resinate sustained release dextromethorphan composition |
| GB8613689D0 (en) | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| GB8613688D0 (en) | 1986-06-05 | 1986-07-09 | Euro Celtique Sa | Pharmaceutical composition |
| US4816264A (en) | 1986-06-06 | 1989-03-28 | Warner-Lambert Company | Sustained release formulations |
| US4985585A (en) | 1988-03-07 | 1991-01-15 | Kyorin Pharmaceutical Co., Ltd. | Phenoxyalkylcarboxylic acid derivatives and process for their preparations |
| JPH07116125B2 (ja) * | 1988-03-07 | 1995-12-13 | 杏林製薬株式会社 | フェノキシアルキルカルボン酸誘導体及びその製造法 |
| US4996047A (en) | 1988-11-02 | 1991-02-26 | Richardson-Vicks, Inc. | Sustained release drug-resin complexes |
| CA2002492A1 (en) | 1988-11-11 | 1990-05-11 | Sandra T. A. Malkowska | Pharmaceutical ion exchange resin composition |
| US5133974A (en) | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| US5290812A (en) | 1991-01-18 | 1994-03-01 | Kyorin Pharmaceutical Co., Ltd. | Phenoxyalkylcarboxylic acid derivatives and process of preparing the same |
| US7064146B2 (en) * | 2003-06-24 | 2006-06-20 | Medicinova, Inc. | Pharmaceutical compositions of isolated orthorhombic crystalline 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid and methods of use |
| US7060854B2 (en) * | 2003-06-24 | 2006-06-13 | Medicinova, Inc. | Process for making polymorphic form A of 4-[6-acetyl-3-[3-(4-acetyl-3-hydroxy-2-propylphenylthio)propoxy]-2-propylphenoxy]butyric acid |
| MXPA06012564A (es) * | 2004-04-27 | 2007-01-31 | Medicinova Inc | Derivados de acido fenoxialquilcarboxilico en el tratamiento de enfermedades inflamatorias. |
| CA2611907A1 (en) * | 2005-06-17 | 2006-12-21 | Boehringer Ingelheim International Gmbh | Mrp iv inhibitors for the treatment of respiratory diseases |
| WO2009002746A1 (en) * | 2007-06-22 | 2008-12-31 | Decode Genetics Ehf. | Dosing schedules of leukotriene synthesis inhibitors for human therapy |
| JP2013119550A (ja) * | 2011-12-08 | 2013-06-17 | Medicinova Inc | 非アルコール性脂肪性肝疾患及び非アルコール性脂肪性肝炎の処置方法 |
-
2014
- 2014-09-18 US US14/490,623 patent/US20150321989A1/en not_active Abandoned
-
2015
- 2015-05-06 KR KR1020167031645A patent/KR102445077B1/ko active IP Right Grant
- 2015-05-06 EP EP20160047.5A patent/EP3763362B1/en active Active
- 2015-05-06 TW TW104114462A patent/TW201622715A/zh unknown
- 2015-05-06 CN CN201580022422.1A patent/CN106232108B/zh active Active
- 2015-05-06 BR BR112016025080A patent/BR112016025080A2/pt not_active Application Discontinuation
- 2015-05-06 WO PCT/US2015/029449 patent/WO2015171749A2/en active Application Filing
- 2015-05-06 ES ES15789358T patent/ES2792850T3/es active Active
- 2015-05-06 CA CA2946594A patent/CA2946594C/en active Active
- 2015-05-06 ES ES20160047T patent/ES2941628T3/es active Active
- 2015-05-06 EP EP15789358.7A patent/EP3139912B1/en active Active
- 2015-05-06 JP JP2016566237A patent/JP6594899B2/ja active Active
-
2016
- 2016-04-21 US US15/134,509 patent/US20170065544A1/en not_active Abandoned
-
2017
- 2017-07-05 US US15/642,316 patent/US20180021275A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3763362A1 (en) | 2021-01-13 |
| CN106232108B (zh) | 2019-11-26 |
| US20170065544A1 (en) | 2017-03-09 |
| US20180021275A1 (en) | 2018-01-25 |
| WO2015171749A2 (en) | 2015-11-12 |
| EP3763362B1 (en) | 2023-01-11 |
| CA2946594A1 (en) | 2015-11-12 |
| EP3139912B1 (en) | 2020-04-08 |
| CN106232108A (zh) | 2016-12-14 |
| JP2017514849A (ja) | 2017-06-08 |
| EP3139912A4 (en) | 2017-11-29 |
| EP3139912A2 (en) | 2017-03-15 |
| TW201622715A (zh) | 2016-07-01 |
| ES2941628T3 (es) | 2023-05-24 |
| CA2946594C (en) | 2022-05-31 |
| JP6594899B2 (ja) | 2019-10-23 |
| US20150321989A1 (en) | 2015-11-12 |
| ES2792850T3 (es) | 2020-11-12 |
| KR102445077B1 (ko) | 2022-09-20 |
| KR20170005810A (ko) | 2017-01-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3140314T3 (da) | Kaloriefrit sødestof | |
| DK3220989T3 (da) | Intranasal administration | |
| BR112016021682A2 (pt) | cenicriviroc para o tratamento da fibrose | |
| DK3224344T3 (da) | Spraytørring | |
| DK3134084T3 (da) | Fremgangsmåde til behandling af lungeadenokarcinom | |
| DK3341479T3 (da) | LNA-G-Proces | |
| DK3231444T3 (da) | Ny behandling | |
| DK3283210T3 (da) | Fremgangsmåde | |
| DK3132009T3 (da) | Fremgangsmåde | |
| BR112017004533A2 (pt) | método para tratamento de sarcoidose pulmonar | |
| DK3160252T3 (da) | Ny fedtfri konfekture | |
| DK3143018T3 (da) | Carboxamidderivater | |
| BR112016026143A2 (pt) | os métodos e composições compreendendo ácido 10-hidroxi-2-decenóico. | |
| HK1244692A1 (zh) | 治療纖維化的方法 | |
| DK2952231T3 (da) | Ketsjer | |
| BR112016025080A2 (pt) | método de tratamento de fibrose pulmonar idiopática. | |
| DK3390621T3 (da) | Forbedret fermentering | |
| DK3285588T3 (da) | Fremgangsmåde | |
| ITUB20153591A1 (it) | Metodo di panificazione | |
| BR112016018539A2 (pt) | revestimento de fácil limpeza. | |
| FI20146111A (fi) | Harja | |
| BR112016028196A2 (pt) | método de inibição ou tratamento de fibrose | |
| ES1148560Y (es) | Cepillo | |
| UA33020S (uk) | Пензель | |
| UA33019S (uk) | Пензель |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |